Results 261 to 270 of about 285,474 (314)
Some of the next articles are maybe not open access.
Endothelin receptor antagonists: a brief review
Canadian Journal of Physiology and Pharmacology, 1994The endothelins are a family of potent vasoconstrictors, some of which also have vasodilatory activity. In many diseases associated with tissue hypoxia or ischemia and in diseases in which vasoconstriction plays a role, the circulating levels of endothelin are higher than in healthy, control subjects.
openaire +2 more sources
Enrasentan, an Antagonist of Endothelin Receptors
Cardiovascular Drug Reviews, 2003ABSTRACTEndothelins are powerful vasoconstrictor agents produced by endothelial cells and identified by Yanagisawa et al. in 1988. Two types of receptors for endothelins have been identified: ETAreceptors are located on smooth muscle cells of the vascular wall and are responsible for endothelin‐induced vasoconstriction while ETBreceptors are located on
openaire +3 more sources
Update on Endothelin Receptor Antagonists in Hypertension
Current Hypertension Reports, 2018M. Burnier
semanticscholar +1 more source
Current treatment and recent progress in gastric cancer
Ca-A Cancer Journal for Clinicians, 2021Smita S Joshi, Brian D Badgwell
exaly
Endothelin receptor antagonists in chronic kidney disease
Nature Reviews NephrologyJ. D. Smeijer +5 more
semanticscholar +1 more source
Critical care management of chimeric antigen receptor T‐cell therapy recipients
Ca-A Cancer Journal for Clinicians, 2022Alexander Shimabukuro-Vornhagen +2 more
exaly